Strides Pharma Science Limited
STAR
Rank in Stocks
#8735
Strides Pharma Science Limited is a pharmaceutical company that focuses on the... Strides Pharma Science Limited is a pharmaceutical company that focuses on the development, production, and worldwide commercialization of medicinal products. Its extensive global footprint spans Africa, Australia, North America, Europe, Asia, India, and various other international markets. The company's operations are structured into two distinct segments: Pharmaceutical and Biopharmaceutical. It provides a diverse range of generic pharmaceuticals, available in multiple formats including tablets, hard and soft gelatin capsules, sachets, liquids, nasal sprays, powders, solids, ointments, and creams. Furthermore, Strides Pharma Science creates branded generic offerings for treating chronic ailments such as women's health issues, central nervous system disorders, cardiovascular conditions, diabetes, dermatological concerns, and probiotic support, marketed under brands like Renerve, Unibrol, Combiart, Duotab, and Vitafer. For institutional business, the company supplies drugs targeting infectious diseases, including anti-retrovirals, anti-malarials, anti-tuberculosis, and Hepatitis treatments. Incorporated in 1990, the company is headquartered in Bengaluru, India. It was formerly known as Strides Shasun Limited before adopting its current name in July 2018.
Share Price
$10.67
Last synced: 2026-11-09
Market Cap
$983.27M
Change (1 day)
0.81%
Change (1 year)
1.99%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Strides Pharma Science Limited (STAR)
Category
Healthcare
Operating Margin for Strides Pharma Science Limited (STAR)
Operating Margin as of November 2026 TTM: 14.17%
According to Strides Pharma Science Limited's latest financial reports, its current operating margin (TTM) is 14.17%. At the end of 2025 the company had an operating margin of 11.58%.
Operating Margin history for Strides Pharma Science Limited from 2004 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 14.17% | 22.37% |
| 2025 | 11.58% | 46.95% |
| 2024 | 7.88% | 133.83% |
| 2023 | 3.37% | -141.05% |
| 2022 | -8.21% | -185.52% |
| 2021 | 9.60% | 22.45% |
| 2020 | 7.84% | -21.60% |
| 2019 | 10.00% | 15.34% |
| 2018 | 8.67% | -39.71% |
| 2017 | 14.38% | 18.06% |
| 2016 | 12.18% | -23.01% |
| 2015 | 15.82% | 6.17% |
| 2014 | 14.90% | -33.54% |
| 2012 | 22.42% | 69.72% |
| 2011 | 13.21% | -32.60% |
| 2010 | 19.60% | 58.58% |
| 2009 | 12.36% | -67.52% |
| 2008 | 38.06% | 239.82% |
| 2007 | 11.20% | -22.49% |
| 2006 | 14.45% | -18.96% |
| 2005 | 17.83% | -5.61% |
| 2004 | 18.89% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -98.63% |
DE
|
|
| 19.68% | -98.61% |
DE
|
|
| 13.26% | -99.06% |
JP
|
|
| 17.08% | -98.79% |
CH
|
|
| 14.92% | -98.95% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Strides Pharma Science Limited's operating margin
What is Strides Pharma Science Limited's operating margin?
Strides Pharma Science Limited's operating margin is 14.17%, as of Nov 2026.
What was Strides Pharma Science Limited's operating margin in 2025?
In 2025, Strides Pharma Science Limited's operating margin was 11.58%, compared with 7.88% in 2024.
How has Strides Pharma Science Limited's operating margin changed since 2020?
From 2020 to 2025, Strides Pharma Science Limited's operating margin was highest in 2025 (11.58%) and lowest in 2022 (-8.21%).
How does Strides Pharma Science Limited's operating margin compare with similar companies?
Strides Pharma Science Limited's operating margin (14.17%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.